Cargando…
Universal Viral Screening of Patients with Newly Diagnosed Cancer in the United States: A Cost-efficiency Evaluation
Recommendations for universal screening of patients with cancer for hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) are inconsistent. A recent multisite screening study (S1204) from the SWOG Cancer Research Network found that a substantial number of patients...
Autores principales: | Vaidya, Riha, Unger, Joseph M., Loomba, Rohit, Hwang, Jessica P., Chugh, Rashmi, Tincopa, Monica A., Arnold, Kathryn B., Hershman, Dawn L., Ramsey, Scott D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541082/ https://www.ncbi.nlm.nih.gov/pubmed/37707388 http://dx.doi.org/10.1158/2767-9764.CRC-23-0255 |
Ejemplares similares
-
Antiviral therapy use and related outcomes in patients with cancer and viral infections: results from SWOG S1204
por: Hwang, Jessica P., et al.
Publicado: (2022) -
Stepwise development of a cancer care delivery research study to evaluate the prevalence of virus infections in cancer patients
por: Unger, Joseph M, et al.
Publicado: (2016) -
Trends in Obesity Prevalence Among Patients Enrolled in Clinical Trials for Obesity-Related Cancers, 1986 to 2016
por: Vaidya, Riha, et al.
Publicado: (2022) -
Association of Patient Demographic Characteristics and Insurance Status With Survival in Cancer Randomized Clinical Trials With Positive Findings
por: Unger, Joseph M., et al.
Publicado: (2020) -
Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation
por: Unger, Joseph M, et al.
Publicado: (2019)